Cargando…

The Unfolded Protein Responses in Health, Aging, and Neurodegeneration: Recent Advances and Future Considerations

Aging and age-related neurodegeneration are both associated with the accumulation of unfolded and abnormally folded proteins, highlighting the importance of protein homeostasis (termed proteostasis) in maintaining organismal health. To this end, two cellular compartments with essential protein foldi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wodrich, Andrew P. K., Scott, Andrew W., Shukla, Arvind Kumar, Harris, Brent T., Giniger, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914544/
https://www.ncbi.nlm.nih.gov/pubmed/35283733
http://dx.doi.org/10.3389/fnmol.2022.831116
Descripción
Sumario:Aging and age-related neurodegeneration are both associated with the accumulation of unfolded and abnormally folded proteins, highlighting the importance of protein homeostasis (termed proteostasis) in maintaining organismal health. To this end, two cellular compartments with essential protein folding functions, the endoplasmic reticulum (ER) and the mitochondria, are equipped with unique protein stress responses, known as the ER unfolded protein response (UPR(ER)) and the mitochondrial UPR (UPR(mt)), respectively. These organellar UPRs play roles in shaping the cellular responses to proteostatic stress that occurs in aging and age-related neurodegeneration. The loss of adaptive UPR(ER) and UPR(mt) signaling potency with age contributes to a feed-forward cycle of increasing protein stress and cellular dysfunction. Likewise, UPR(ER) and UPR(mt) signaling is often altered in age-related neurodegenerative diseases; however, whether these changes counteract or contribute to the disease pathology appears to be context dependent. Intriguingly, altering organellar UPR signaling in animal models can reduce the pathological consequences of aging and neurodegeneration which has prompted clinical investigations of UPR signaling modulators as therapeutics. Here, we review the physiology of both the UPR(ER) and the UPR(mt), discuss how UPR(ER) and UPR(mt) signaling changes in the context of aging and neurodegeneration, and highlight therapeutic strategies targeting the UPR(ER) and UPR(mt) that may improve human health.